AcroBel - The Belgian registry on acromegaly: A survey of the 'real-life' outcome in 418 acromegalic subjects

European Journal of Endocrinology

Volumn 157, Issue 4, 2007, Pages 399-409

  Bex, Marie ^a   Abs, Roger ^b   T'Sjoen, Guy ^c   Mockel, Jean ^d   Velkeniers, Brigitte ^e   Muermans, Katja ^f   Maiter, Dominique ^g  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f Medical Department   (Belgium)

^g Hôpital Saint Luc   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGE; AGED; ARTICLE; BELGIUM; BIOCHEMISTRY; CONTROLLED STUDY; DEATH; DISEASE CONTROL; DISEASE REGISTRY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; HYPOPHYSECTOMY; HYPOPHYSIS ADENOMA; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; TREATMENT OUTCOME;

ACROMEGALY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPATHY, NEUROGENIC; BELGIUM; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIABETES COMPLICATIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; LUXEMBOURG; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; REGISTRIES;

EID: 35549010686     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0358     Document Type: Article

References (33)

1. Melmed S. Acromegaly. New England Journal of Medicine 2006 355 2558-2573.
2. Bates AS, Van't Hoff W, Jones JM & Clayton RN. An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine 1993 86 293-299.
3. Orme SM, McNally RJQ, Cartwright RA, Belchetz PE for the United Kingdom Acromegaly Study Group Mortality and cancer incidence in acromegaly: a retrospective cohort study. Journal of Clinical Endocrinology and Metabolism 1998 83 2730-2734.
4. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM & Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 1613-1617.
5. Kauppinen-Mäkelin R, Sane T, Reunanen A, Välimäki PJ, Niskanen L, Markkanen H, Löyttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UF, Viikari J & Voutilainen E. A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 4081-4086.
6. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674.
7. Swearingen B, Barker FG II, Katznelson L, Biller BMK, Grinspoon S, Klibanski A, Moayeri N, Black PMCL & Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3419-3426.
8. Beauregard C, Truong U, Hardy J & Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology 2002 58 86-91.
9. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW Schutte PJ, van Dulken H, Romijn JA & Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insuline-like growth factor I measurements. Journal of Clinical Endocrinology and Metabolism 2004 89 2789-2796.
10. Guistina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldbuis J, Wass J, Von Werder K & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
11. Katznelson L, Kleinberg D, Vance ML, Stravou S, Mulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ & Klibanski A. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clinical Endocrinology 2000 54 183-188.
12. Mestrón A, Webb SA, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vasquez JA, Zamora J, Albareda M, Gilabert M & on behalf of all the REA participants. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA). European Journal of Endocrinology 2004 151 439-446.
13. Reincke M, Petersenn S, Buchfelder M, Gerbert B, Skrobek-Engel G, Franz H, Lohmann R & Quabbe HJ. The German Acromegaly Registry: description of the database and initial results. Experimental and Clinical Endocrinology and Diabetes 2006 114 498-505.
14. Drange MR, Fram NR, Herman-Bonert V & Melmed S. Pituitary tumor registry: a novel clinical resource. Journal of Clinical Endocrinology and Metabolism 2000 85 168-174.
15. Webb SM, Prieto L, Badia X, Albareda M, Catal a M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Helperin I, Obiols G & Astorga R. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clinical Endocrinology 2002 57 251-258.
16. T'Sjoen G, Bex M, Maiter D, Velkeniers B & Abs R. Health related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly, European Journal of Endocrinology 2007 157 411-417.
17. Brabant G, von zur Mühlen A, Wüster C, Ranke MB, Kratzsch J, Kiess W Ketelslegers JM, Wilhemsen L, Hulthén L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P; on behalf of the German KIMS Board. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research 2003 60 53-60.
18. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons, C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM. Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T & Wood D; European Society of Cardiology, American Heart Association, American College of Cardiology. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Atherosclerosis 2004 173 381-391.
19. Holdaway IM & Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999 2 29-41.
20. Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, Bonelli M, Lancranjan I & Pagani G. Cholelithiasis and acreomagly: therapeutic strategies. Clinical Endocrinology 1994 40 401-406.
21. Jenkins PJ & Besser M. Acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism 2001 86 2935-2941.
22. Melmed S. Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology and Metabolism 2001 86 2929-2934.
23. Darzy KH & Shalet SM. Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 2005 8 203-211.
24. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM Association between premature mortality and hypopituitarism. The West Midlands Prospective Hypopituitary Study Group. Lancet 2001 357 425-431.
25. Biochemical assessment and long term monitoring in patients with acromegaly: statement from a Joint Consensus Conference of the Growth Hormone Research Society and the Pituitary Society. Journal of Clinical Endocrinology and Metabolism 2004 89 3099-3102.
26. Ronchi CL, Varca V, Giavoli C, Epaminonda P, Beck-Peccoz P, Spada A & Arosio M. Long-term evaluation of postoperative acromegatic patients in remission with previous and newly proposed criteria. Journal of Clinical Endocrinology and Metabolism 2005 90 1377-1382.
27. Biermasz NR, van Dulken H & Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 4596-4602.
28. Newman CB, Melmed S, George A, Torigian D, Duchaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L & Kleinberg DL. Octreotide as primary therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3034-3040.
29. Freda PU, Katznelson L, vander Lely AJ, Reyes CM, Zhao S & Rabinowitz D. Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2005 90 4465-4473.
30. Cozzi R, Montini M, Attanasio R, Albizzi M, Lasio G, Lodrini S, Doneda P, Cortesi L & Pagani G. Primary treatment of acromegaly with octrotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. Journal of Clinical Endocrinology and Metabolism 2006 91 1397-1403.
31. Colao A, Pivonello R, Auriemma RS, Briganti F, Galdiero M, Tortora F. Caranci F, Cirillo S & Lombardi G. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. Journal of Clinical Endocrinology and Metabolism 2006 91 2112-2118.
32. Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G & Cozzi R. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostin analogs in acromegaly. Journal of Clinical Endocrinology and Metabolism 2006 91 85-92.
33. Jaquet P, Cortet-Rudelli Ch, Sassolas G, Morange-Ramos I, Chanson P, Brue T, Andrieu JP, Beckers A, Bertherat J, Borson-Chazot F, Brassier G, Caron P, Cogne M, Cottier JP, Delemer B, Dufour H, Enjalbert A, Figarella Branger D, Gaillard R, Gueydan M, Jan M, Kuhn JM, Raingeard I, Regis J, Roger P, Rohmer V, Sadoul JL, Saveanu A, Tabarin A, Travers N, Trouillas J & the French Acromegaly Registry. Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry. Annales d'Endocrinologie 2003 64 434-441.